Teladoc Health, Inc. (LON:0LDR)
London · Delayed Price · Currency is GBP · Price in USD 8.53
+0.20 (2.36%)
At close: Oct 23, 2025
Teladoc Health Market Cap
Teladoc Health has a market cap or net worth of 1.14 billion as of October 24, 2025. Its market cap has increased by 0.07% in one year.
Market Cap
1.14B
Enterprise Value
1.41B
Revenue
1.86B
Ranking
n/a
PE Ratio
n/a
Stock Price
8.53
Market Cap Chart
Since July 1, 2015, Teladoc Health's market cap has increased from 675.25M to 1.14B, an increase of 68.92%. That is a compound annual growth rate of 5.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2025 | 1.14B | -8.76% |
| Dec 31, 2024 | 1.25B | -55.37% |
| Dec 29, 2023 | 2.80B | -11.87% |
| Dec 30, 2022 | 3.18B | -70.72% |
| Dec 31, 2021 | 10.86B | -48.87% |
| Dec 31, 2020 | 21.23B | 364.01% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 194.46B |
| GSK plc | 66.45B |
| Haleon | 31.57B |
| Smith & Nephew | 11.83B |
| ConvaTec Group | 4.95B |
| Hikma Pharmaceuticals | 3.95B |
| HUTCHMED (China) | 1.96B |
| Genus | 1.74B |